SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

The Kraft Heinz Co. engages in the manufacture and market of food and beverage products. It operates through the North America and International geographical segments. The company was founded on July 2, 2015, and is headquartered in Pittsburgh, PA.

Kraft Heinz Co

Kraft Heinz is trending as the market reacts to a recent analyst downgrade and the upcoming leadership transition with a new CEO, alongside plans to split into two independent companies by 2026. The community is deeply divided, with many seeing KHC as a severely undervalued, recession-proof dividend play ripe for accumulation, while others express skepticism about its growth prospects amidst perceived market manipulation. This discussion comes as some investors consider rotating from high-flying tech into defensive consumer staples.

USELESS

USELESS CRYPTO is trending as it gains traction from recent listings on major exchanges and expanded cross-chain capabilities via Chainlink CCIP. The community is actively discussing its potential for substantial market cap growth, fueled by perceived accumulation from large investors and embracing its self-aware "useless" branding as a unique value proposition.

The ticket is $Testicle. EVERY SINGLE ONE OF YOU CAME FROM A $Testicle. $Testicle always bounce.   We have a website on which you can create art or memes. We have a community. We have a raid group. We aim to provide the best testicular care on CT.   We might even have to call on our nefarious leader, Harry Bolz. Alright Chad, SACK TF. Or else you’re a Low T beta male.   If you have questions and or concerns please feel to reach out to a team member on how you can acquire or become a high testosterone male in a sea of betas. I mean how else does one live if not as a High T male?

Testicle

TESTICLE CRYPTO is drawing significant community attention within the volatile digital asset space, driven by highly speculative discussions around its future value. Enthusiasts are actively touting its potential, often referencing it alongside major cryptocurrencies as part of the broader conversation on rapidly emerging tokens.

SuperRare

SuperRare ($RARE) is seeing immense community activity, fueled by its recent strong price movements and technical indicators suggesting further upward momentum. The conversation centers on "whale" accumulation and a strong belief among participants that the NFT platform's token is significantly undervalued, with many anticipating substantial gains.

Binance Coin is the cryptocurrency of the Binance platform. It is a trading platform exclusively for cryptocurrencies. The name "Binance" is a combination of binary and finance.  Thus, the startup name shows that only cryptocurrencies can be traded against each other. It is not possible to trade crypto currencies against Fiat. The platform achieved an enormous success within a very short time and is focused on worldwide market with Malta headquarters. The cryptocurrency currently has a daily trading volume of 1.5 billion - 2 billion US dollars and is still increasing.  In total, there will only be 200 million BNBs. Binance uses the ERC20 token standard from Ethereum and has distributed it as follow: 50% sold on ICO, 40% to the team and 10% to Angel investors. The coin can be used to pay fees on Binance. These include trading fees, transaction fees, listing fees and others. Binance gives you a huge discount when fees are paid in BNB.   The schedule of BNB fees discount is as follow: In the first year, 50% discount on all fees, second year 25% discount, third year 12.5% discount, fourth year 6.75 % discount, and from the fifth year onwards there is no discount. This structure is used to incentivize users to buy BNB and do trades within Binance.  Binance announced in a buyback plan that it would buy back up to 100 million BNB in Q1 2018. The coins are then burned. This means that they are devaluated to increase the value of the remaining coins. This benefits investors. In the future, the cryptocurrency will remain an asset on the trading platform and will be used as gas.  Other tokens that are issued by exchanges include Bibox Token, OKB, Huobi Token, and more.

Binance

BNB is drawing significant attention after the pardon of Binance founder CZ, fueling community discussion about his potential influence on the US crypto landscape and the token's future. The Binance ecosystem demonstrates robust expansion with new services, institutional integrations like BlackRock's BUIDL fund, and continuous token burns, all contributing to an active trading environment where technical analysts anticipate further price movements.

PolySwarm

PolySwarm (NCT) is actively discussed for its robust utility in AI-driven cybersecurity, with the community noting its 100% circulating supply and low market cap as key drivers for potential significant upside. Amid broader market shifts, investors are closely watching for a breakout, with many accumulating tokens in anticipation of an altcoin season and a major pump.

REGENXBIO, Inc. is a clinical-stage biotechnology company, which engages in the development, commercialization, and licensing of recombinant adeno-associated virus gene therapy. Its product candidates include the NAV Technology Platform, which consists of exclusive rights to novel adeno-associated viral vectors, and therapeutic programs such as RGX-314, RGX-202, RGX-121, RGX-111, RGX-181, and RGX-381. The company was founded by Kenneth T. Mills and James M. Wilson on July 16, 2008 and is headquartered in Rockville, MD.

Regenxbio Inc

Regenxbio is trending due to significant advancements in its pipeline, highlighted by positive long-term data for its Duchenne Muscular Dystrophy gene therapy, RGX-202, and the recent FDA Priority Review acceptance for RGX-121 in Hunter Syndrome with an upcoming PDUFA target. Adding to the momentum, a new strategic partnership has provided substantial upfront funding and potential future milestones, bolstering its financial strength. The investing community is actively discussing RGX-121's strong approval prospects and RGX-202's differentiated safety profile as a potential best-in-class treatment, particularly within the evolving gene therapy landscape.

Nuvation Bio, Inc. is a biopharmaceutical company tackling some of the unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its proprietary portfolio includes six novel and mechanistically distinct oncology therapeutic product candidates, each targeting some of the most difficult-to-treat types of cancer. The company was founded by David Hung on March 20, 2018 and is headquartered in New York, NY.

Nuvation Bio Inc - Ordinary Shares - Class A

Nuvation Bio is gaining significant attention following robust early sales for its FDA-approved lung cancer drug IBTROZI and a new global licensing agreement with Eisai, further solidifying its market position. The community is buzzing about the strong Phase 2 data for its promising glioma asset, safusidenib, and praising CEO David Hung's strategic leadership, anticipating substantial long-term growth and potential for a major buyout.

Global X Funds - Global X Dow 30 Covered Call ETF

Global X Dow 30 Covered Call ETF

The Dow Jones Industrial Average is trending as the market keenly anticipates the Federal Reserve's next moves on interest rates, especially amid widespread discussion regarding potential changes in Fed leadership and broader central bank independence. Mixed signals from recent labor market data are fueling a divided community sentiment, with some traders holding onto hopes for a year-end rally while others warn of an overbought market facing economic uncertainties.

Teladoc Health, Inc. engages in the provision of telehealthcare services using a technology platform via mobile devices, the Internet, video and phone. It operates through the following segments: Teladoc Health Integrated Care, BetterHelp, and Others. The Teladoc Health Integrated Care segment offers virtual medical services. The BetterHelp segment includes virtual mental health and other wellness services. The company was founded in June 2002 by George Byron Brooks, Michael Gorton, and Gary Wald and is headquartered in New York, NY.

Teladoc Health Inc

Teladoc Health is trending following its J.P. Morgan conference presentation outlining strategic pivots into AI, GLP-1 weight management, and expanding BetterHelp's insurance coverage, amidst the DEA's extended telehealth prescribing. Investor sentiment remains sharply divided; while many express frustration over persistent stock lows and management's performance, others view it as a deeply undervalued global leader in virtual care with strong cash flow and short squeeze potential, seeing a setup similar to past significant rebounds in highly shorted names.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

WATCHLIST OCT 25 2024..

$SEIC Morgan Stanley Maintains Underweight on SEI Inv, Raises Price Target to $75

$VBTX DA Davidson Maintains Buy on Veritex Holdings, Raises Price Target to $33

$NBHC DA Davidson Maintains Buy on National Bank Holdings, Raises Price Target to $53

$NBR Susquehanna Maintains Neutral on Nabors Industries, Lowers Price Target to $77

$BA Susquehanna Maintains Positive on Boeing, Lowers Price Target to $200

Myles Brewer

Ryan Evans

John Doe

Paul Wolfe

StockTwits for iOS

SEI Investments Co.

Boeing Co

Nabors Industries Ltd

Veritex Holdings Inc

National Bank Holdings Corp - Ordinary Shares - Class A

 Morgan Stanley Maintains Underweight on SEI Inv, Raises Price Target to $75



 DA Davidson Maintains Buy on Veritex Holdings, Raises Price Target to $33



 DA Davidson Maintains Buy on National Bank Holdings, Raises Price Target to $53



 Susquehanna Maintains Neutral on Nabors Industries, Lowers Price Target to $77



 Susquehanna Maintains Positive on Boeing, Lowers Price Target to $200